Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-17

FDA Approved: QLOSI — Original Application (Orasis Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved QLOSI (pilocarpine hydrochloride) from Orasis Pharmaceuticals in its original NDA (NDA217836) for presbyopia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Qlosi

Snippet

ORIG AP for QLOSI (PILOCARPINE HYDROCHLORIDE)